Diagnosis and Treatment > Signs and Symptoms

You are looking at 1 - 3 of 3 items for :

  • Hypokalaemia x
Clear All
Sofia Pilar Ildefonso-Najarro Division of Endocrinology, Guillermo Almenara Irigoyen National Hospital, Lima, Peru

Search for other papers by Sofia Pilar Ildefonso-Najarro in
Google Scholar
PubMed
Close
,
Esteban Alberto Plasencia-Dueñas Division of Endocrinology, Guillermo Almenara Irigoyen National Hospital, Lima, Peru

Search for other papers by Esteban Alberto Plasencia-Dueñas in
Google Scholar
PubMed
Close
,
Cesar Joel Benites-Moya National University of Trujillo, School of Medicine, Trujillo, Peru

Search for other papers by Cesar Joel Benites-Moya in
Google Scholar
PubMed
Close
,
Jose Carrion-Rojas Metabolism and Reproduction Unit, Division of Endocrinology, Guillermo Almenara Irigoyen National Hospital, Lima, Peru

Search for other papers by Jose Carrion-Rojas in
Google Scholar
PubMed
Close
, and
Marcio Jose Concepción-Zavaleta Division of Endocrinology, Guillermo Almenara Irigoyen National Hospital, Lima, Peru

Search for other papers by Marcio Jose Concepción-Zavaleta in
Google Scholar
PubMed
Close

Summary

Cushing’s syndrome is an endocrine disorder that causes anovulatory infertility secondary to hypercortisolism; therefore, pregnancy rarely occurs during its course. We present the case of a 24-year-old, 16-week pregnant female with a 10-month history of unintentional weight gain, dorsal gibbus, nonpruritic comedones, hirsutism and hair loss. Initial biochemical, hormonal and ultrasound investigations revealed hypokalemia, increased nocturnal cortisolemia and a right adrenal mass. The patient had persistent high blood pressure, hyperglycemia and hypercortisolemia. She was initially treated with antihypertensive medications and insulin therapy. Endogenous Cushing’s syndrome was confirmed by an abdominal MRI that demonstrated a right adrenal adenoma. The patient underwent right laparoscopic adrenalectomy and anatomopathological examination revealed an adrenal adenoma with areas of oncocytic changes. Finally, antihypertensive medication was progressively reduced and glycemic control and hypokalemia reversal were achieved. Long-term therapy consisted of low-dose daily prednisone. During follow-up, despite favorable outcomes regarding the patient’s Cushing’s syndrome, stillbirth was confirmed at 28 weeks of pregnancy. We discuss the importance of early diagnosis and treatment of Cushing’s syndrome to prevent severe maternal and fetal complications.

Learning points:

  • Pregnancy can occur, though rarely, during the course of Cushing’s syndrome.

  • Pregnancy is a transient physiological state of hypercortisolism and it must be differentiated from Cushing’s syndrome based on clinical manifestations and laboratory tests.

  • The diagnosis of Cushing’s syndrome during pregnancy may be challenging, particularly in the second and third trimesters because of the changes in the maternal hypothalamic-pituitary-adrenal axis.

  • Pregnancy during the course of Cushing’s syndrome is associated with severe maternal and fetal complications; therefore, its early diagnosis and treatment is critical.

Open access
Wei Yang Division of Endocrinology, Department of Internal Medicine

Search for other papers by Wei Yang in
Google Scholar
PubMed
Close
,
David Pham Department of Radiology, University of California Davis School of Medicine, Sacramento, California, USA

Search for other papers by David Pham in
Google Scholar
PubMed
Close
,
Aren T Vierra Division of Endocrinology, Department of Internal Medicine

Search for other papers by Aren T Vierra in
Google Scholar
PubMed
Close
,
Sarah Azam Division of Endocrinology, Department of Internal Medicine

Search for other papers by Sarah Azam in
Google Scholar
PubMed
Close
,
Dorina Gui Department of Pathology, University of California Davis School of Medicine, Sacramento, California, USA

Search for other papers by Dorina Gui in
Google Scholar
PubMed
Close
, and
John C Yoon Division of Endocrinology, Department of Internal Medicine

Search for other papers by John C Yoon in
Google Scholar
PubMed
Close

Summary

Ectopic ACTH-secreting pulmonary neuroendocrine tumors are rare and account for less than 5% of endogenous Cushing’s syndrome cases. We describe an unusual case of metastatic bronchial carcinoid tumor in a young woman presenting with unprovoked pulmonary emboli, which initially prevented the detection of the primary tumor on imaging. The source of ectopic ACTH was ultimately localized by a Gallium-DOTATATE scan, which demonstrated increased tracer uptake in a right middle lobe lung nodule and multiple liver nodules. The histological diagnosis was established based on a core biopsy of a hepatic lesion and the patient was started on a glucocorticoid receptor antagonist and a somatostatin analog. This case illustrates that hypercogulability can further aggravate the diagnostic challenges in ectopic ACTH syndrome. We discuss the literature on the current diagnosis and management strategies for ectopic ACTH syndrome.

Learning points:

  • In a young patient with concurrent hypokalemia and uncontrolled hypertension on multiple antihypertensive agents, secondary causes of hypertension should be evaluated.

  • Patients with Cushing’s syndrome can develop an acquired hypercoagulable state leading to spontaneous and postoperative venous thromboembolism.

  • Pulmonary emboli may complicate the imaging of the bronchial carcinoid tumor in ectopic ACTH syndrome.

  • Imaging with Gallium-68 DOTATATE PET/CT scan has the highest sensitivity and specificity in detecting ectopic ACTH-secreting tumors.

  • A combination of various noninvasive biochemical tests can enhance the diagnostic accuracy in differentiating Cushing’s disease from ectopic ACTH syndrome provided they have concordant results. Bilateral inferior petrosal sinus sampling remains the gold standard.

Open access
Carine Ghassan Richa Department of Endocrinology, Mount Lebanon Hospital, Beirut, Lebanon
Lebanese University, Hadath, Lebanon

Search for other papers by Carine Ghassan Richa in
Google Scholar
PubMed
Close
,
Khadija Jamal Saad Department of Endocrinology, Mount Lebanon Hospital, Beirut, Lebanon
Lebanese University, Hadath, Lebanon

Search for other papers by Khadija Jamal Saad in
Google Scholar
PubMed
Close
,
Georges Habib Halabi Department of Endocrinology, Mount Lebanon Hospital, Beirut, Lebanon
Mount Lebanon Hospital, Beirut, Lebanon

Search for other papers by Georges Habib Halabi in
Google Scholar
PubMed
Close
,
Elie Mekhael Gharios Department of Endocrinology, Mount Lebanon Hospital, Beirut, Lebanon
Mount Lebanon Hospital, Beirut, Lebanon

Search for other papers by Elie Mekhael Gharios in
Google Scholar
PubMed
Close
,
Fadi Louis Nasr Mount Lebanon Hospital, Beirut, Lebanon

Search for other papers by Fadi Louis Nasr in
Google Scholar
PubMed
Close
, and
Marie Tanios Merheb Department of Endocrinology, Mount Lebanon Hospital, Beirut, Lebanon
Mount Lebanon Hospital, Beirut, Lebanon

Search for other papers by Marie Tanios Merheb in
Google Scholar
PubMed
Close

Summary

The objective of this study is to report three cases of paraneoplastic or ectopic Cushing syndrome, which is a rare phenomenon of the adrenocorticotropic hormone (ACTH)-dependent Cushing syndrome. Three cases are reported in respect of clinical presentation, diagnosis and treatment in addition to relevant literature review. The results showed that ectopic ACTH secretion can be associated with different types of neoplasm most common of which are bronchial carcinoid tumors, which are slow-growing, well-differentiated neoplasms with a favorable prognosis and small-cell lung cancer, which are poorly differentiated tumors with a poor outcome. The latter is present in two out of three cases and in the remaining one, primary tumor could not be localized, representing a small fraction of patients with paraneoplastic Cushing. Diagnosis is established in the setting of high clinical suspicion by documenting an elevated cortisol level, ACTH and doing dexamethasone suppression test. Treatment options include management of the primary tumor by surgery and chemotherapy and treating Cushing syndrome. Prognosis is poor in SCLC. We concluded that in front of a high clinical suspicion, ectopic Cushing syndrome diagnosis should be considered, and identification of the primary tumor is essential.

Learning points:

  • Learning how to suspect ectopic Cushing syndrome and confirm it among all the causes of excess cortisol.

  • Distinguish between occult and severe ectopic Cushing syndrome and etiology.

  • Providing the adequate treatment of the primary tumor as well as for the cortisol excess.

  • Prognosis depends on the differentiation and type of the primary malignancy.

Open access